These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28401745)

  • 21. Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation.
    Shaw PJ; Bergin ME; Burgess MA; Dalla Pozza L; Kellie SJ; Rowell G; Stevens MM; Webster BH; Bradstock KF
    J Clin Oncol; 1994 Oct; 12(10):2138-45. PubMed ID: 7931485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reciprocal bone marrow transplantation between brother and sister.
    Rana I; Pinto RM; Caniglia M; Lombardi A; De Rossi G
    Bone Marrow Transplant; 2002 Apr; 29(8):705-7. PubMed ID: 12180117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in second remission or relapse.
    Lin KH; Jou ST; Chen RL; Lin DT; Lui LT; Lin KS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1994; 35(6):487-94. PubMed ID: 7831980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T; Kojima S; Kato K
    Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F; Pession A; Zecca M; Bonetti F; Prete L; Carrà AM; Prete A; Montagna D; Comoli P; Taibi RM; Paolucci G
    Bone Marrow Transplant; 1996 Jan; 17(1):31-7. PubMed ID: 8673051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
    Ishida H; Adachi S; Hasegawa D; Okamoto Y; Goto H; Inagaki J; Inoue M; Koh K; Yabe H; Kawa K; Kato K; Atsuta Y; Kudo K
    Pediatr Blood Cancer; 2015 May; 62(5):883-9. PubMed ID: 25545836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
    Huang H; Lin M; Meng H
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three AML patients with existing or pre-existing intracerebral granulocytic sarcomas who were successfully treated with allogeneic bone marrow transplantations.
    Takada S; Ito K; Sakura T; Hatsumi N; Sato M; Saito T; Shiozaki H; Matsushima T; Miyawaki S
    Bone Marrow Transplant; 1999 Apr; 23(7):731-4. PubMed ID: 10218852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unrelated donor bone marrow transplantation for children with acute leukemia.
    Davies SM; Wagner JE; Shu XO; Blazar BR; Katsanis E; Orchard PJ; Kersey JH; Dusenbery KE; Weisdorf DJ; McGlave PB; Ramsay NK
    J Clin Oncol; 1997 Feb; 15(2):557-65. PubMed ID: 9053477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
    Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of allogenic and autologous bone marrow transplantation in children with acute myeloid leukemia].
    Hermann J; Fuchs D; Prager J; Palme H; Müller A; Füller J; Vogelsang H; Zintl F
    Kinderarztl Prax; 1992 Apr; 60(2):35-9. PubMed ID: 1608183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission.
    Dufoir T; Saux MC; Terraza B; Marit G; Guessard S; Foulon G; Reiffers J
    Bone Marrow Transplant; 1992 Oct; 10(4):323-9. PubMed ID: 1422487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful bone marrow transplantation from an unrelated donor in a child with AML in second remission.
    Dopfer R; Ehninger G; Schmidt H; Waller HD; Niethammer D
    Blut; 1987 Oct; 55(4):199-204. PubMed ID: 3311227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of dynamic detection of WT1 expression on monitoring minimal residual disease in leukemia patients following allogeneic bone marrow transplantation].
    Gu WY; Chen ZX; Hu SY; Zhu J; Wang ZL; Yan F; Wang W; Cen JN; Shen HL; Qian J
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):444-7. PubMed ID: 15854547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission.
    Schiller GJ; Nimer SD; Territo MC; Ho WG; Champlin RE; Gajewski JL
    J Clin Oncol; 1992 Jan; 10(1):41-6. PubMed ID: 1727924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful Cytoreduction with CAG (cytarabine, Aclarubicin and G-CSF) Therapy in Refractory Acute Myelogenous Leukemia before Allogeneic Stem Cell Transplantation.
    Murayama T; Imoto S; Gomyo H; Mizuno I; Kajimoto K; Sugimoto T; Tobinai K; Koizumi T
    Hematology; 2001; 6(6):381-5. PubMed ID: 27405694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow transplantation for childhood acute myelogenous leukemia.
    Lin KH; Jou ST; Chen RL; Lin DT; Lin KS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1994; 35(5):415-22. PubMed ID: 7942028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.